questionsmedicales.fr
Composés hétérocycliques
Oxydes hétérocycliques
N-oxydes cycliques
N-oxydes cycliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "N-oxydes cycliques : Questions médicales les plus fréquentes",
"headline": "N-oxydes cycliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les N-oxydes cycliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "N-oxydes cycliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxydes hétérocycliques",
"url": "https://questionsmedicales.fr/mesh/D006577",
"about": {
"@type": "MedicalCondition",
"name": "Oxydes hétérocycliques",
"code": {
"@type": "MedicalCode",
"code": "D006577",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.661"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "4-Hydroxyamino quinoléine 1-oxyde",
"alternateName": "4-Hydroxyaminoquinoline-1-oxide",
"url": "https://questionsmedicales.fr/mesh/D015108",
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxyamino quinoléine 1-oxyde",
"code": {
"@type": "MedicalCode",
"code": "D015108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.661.243.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "4-Nitro-quinoléine-1-oxyde",
"alternateName": "4-Nitroquinoline-1-oxide",
"url": "https://questionsmedicales.fr/mesh/D015112",
"about": {
"@type": "MedicalCondition",
"name": "4-Nitro-quinoléine-1-oxyde",
"code": {
"@type": "MedicalCode",
"code": "D015112",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.661.243.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle",
"alternateName": "Triacetoneamine-N-Oxyl",
"url": "https://questionsmedicales.fr/mesh/D014216",
"about": {
"@type": "MedicalCondition",
"name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle",
"code": {
"@type": "MedicalCode",
"code": "D014216",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.661.243.930"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "N-oxydes cycliques",
"alternateName": "Cyclic N-Oxides",
"code": {
"@type": "MedicalCode",
"code": "D003497",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Youai Qiu",
"url": "https://questionsmedicales.fr/author/Youai%20Qiu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory and Institute of Elemento-Organic Chemistry, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, 94 Weijin Road, Tianjin, 300071, China."
}
},
{
"@type": "Person",
"name": "Jiawei Wang",
"url": "https://questionsmedicales.fr/author/Jiawei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China."
}
},
{
"@type": "Person",
"name": "Wei Wu",
"url": "https://questionsmedicales.fr/author/Wei%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China. Electronic address: wuwei@xaut.edu.cn."
}
},
{
"@type": "Person",
"name": "Yaqi Huang",
"url": "https://questionsmedicales.fr/author/Yaqi%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China."
}
},
{
"@type": "Person",
"name": "Maosheng Zheng",
"url": "https://questionsmedicales.fr/author/Maosheng%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Regional Energy Systems Optimization, Ministry of Education, College of Environmental Science and Technology, North China Electric Power University, Beijing, 102206, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Patient satisfaction - results of cluster analysis of finnish patients.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37312180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-09625-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "RNAprofiling 2.0: Enhanced Cluster Analysis of Structural Ensembles.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36933824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmb.2023.168047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of the Intelligent Tourism Route Planning Scheme Based on the Cluster Analysis Algorithm.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35800698",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/3310676"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of Graphic Perception Education for Young Children Based on Fuzzy Clustering Analysis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35774433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8046713"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparative Analysis of the Performance of Complex Texture Clustering Driven by Computational Intelligence Methods Using Multiple Clustering Models.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36210982",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/8449491"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Oxydes hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006577"
},
{
"@type": "ListItem",
"position": 4,
"name": "N-oxydes cycliques",
"item": "https://questionsmedicales.fr/mesh/D003497"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : N-oxydes cycliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur N-oxydes cycliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur N-oxydes cycliques",
"description": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?\nQuels tests sont utilisés pour détecter les N-oxydes cycliques ?\nQuels symptômes indiquent une exposition aux N-oxydes cycliques ?\nLes N-oxydes cycliques sont-ils visibles sur des imageries médicales ?\nPeut-on identifier les N-oxydes cycliques dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur N-oxydes cycliques",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes N-oxydes cycliques provoquent-ils des allergies ?\nY a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?\nLes symptômes varient-ils selon le type de N-oxyde ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur N-oxydes cycliques",
"description": "Comment prévenir l'exposition aux N-oxydes cycliques ?\nDes formations sont-elles nécessaires pour manipuler ces composés ?\nQuels équipements de protection sont recommandés ?\nLes réglementations aident-elles à prévenir l'exposition ?\nComment évaluer les risques d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur N-oxydes cycliques",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les N-oxydes cycliques ?\nComment traiter les symptômes respiratoires ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur N-oxydes cycliques",
"description": "Quelles complications peuvent survenir après exposition ?\nLes N-oxydes cycliques peuvent-ils causer des cancers ?\nY a-t-il des effets à long terme sur la santé ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur N-oxydes cycliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il la sensibilité aux N-oxydes cycliques ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes femmes enceintes sont-elles plus à risque ?\nLe mode de vie influence-t-il le risque d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Cluster+Analysis&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les N-oxydes cycliques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux N-oxydes cycliques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles respiratoires, des nausées et des vertiges."
}
},
{
"@type": "Question",
"name": "Les N-oxydes cycliques sont-ils visibles sur des imageries médicales ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas visibles sur les imageries médicales standard."
}
},
{
"@type": "Question",
"name": "Peut-on identifier les N-oxydes cycliques dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins spécifiques peuvent détecter leur présence."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les N-oxydes cycliques provoquent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des réactions allergiques chez certaines personnes sensibles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des problèmes respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de N-oxyde ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique spécifique."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver avec une exposition continue ou répétée."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux N-oxydes cycliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Des formations sont-elles nécessaires pour manipuler ces composés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation adéquate est essentielle pour manipuler ces substances en toute sécurité."
}
},
{
"@type": "Question",
"name": "Quels équipements de protection sont recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des gants, des lunettes de protection et des masques respiratoires sont recommandés."
}
},
{
"@type": "Question",
"name": "Les réglementations aident-elles à prévenir l'exposition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations strictes encadrent l'utilisation de ces composés dans l'industrie."
}
},
{
"@type": "Question",
"name": "Comment évaluer les risques d'exposition ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations de risques régulières doivent être effectuées dans les environnements de travail."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les N-oxydes cycliques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour ces composés."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes respiratoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bronchodilatateurs et les corticostéroïdes peuvent être utilisés pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Le traitement nécessite-t-il une hospitalisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures de sécurité et des équipements de protection individuelle sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires et neurologiques peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les N-oxydes cycliques peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme sur la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles respiratoires chroniques et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis médicaux réguliers sont nécessaires pour surveiller les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et en industrie chimique sont les plus exposés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux N-oxydes cycliques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires augmentent le risque d'effets néfastes."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition pendant la grossesse peut affecter le fœtus et la mère."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'exposition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie avec des expositions professionnelles augmente le risque."
}
}
]
}
]
}
Healthcare providers must understand patients' expectations and perceptions of the care they receive to provide high-quality care. The purpose of this study is to identify and analyse different cluste...
A cross-sectional design was applied. The data were collected in 2017 from three Finnish acute care hospitals with the Revised Humane Caring Scale (RHCS) as a paper questionnaire, including six backgr...
A total of 1810 patients participated in the study. Patient satisfaction was categorised into four groups: dissatisfied (n = 58), moderately dissatisfied (n = 249), moderately satisfied (n = 608), and...
The results mostly demonstrated high levels of patient satisfaction; however, the perceptions of minority populations of dissatisfied patients should be assessed to identify shortcomings in the care p...
Understanding the base pairing of an RNA sequence provides insight into its molecular structure. By mining suboptimal sampling data, RNAprofiling 1.0 identifies the dominant helices in low-energy seco...
In view of the problems of the traditional cluster analysis algorithm such as strong dependence on the initial cluster center, the traditional...
Geometric ability includes elements of identification, conceptualization, combination, drawing, and reasoning, and graphic perception is an important part of it. Kindergarten science education include...
Traditional texture cluster algorithms are frequently used in engineering; however, despite their widespread application, these algorithms continue to suffer from drawbacks including excessive complex...
Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic consequences and the heavy financial burden incurred by cancer patients....
We conducted a cross-sectional survey of adult patients at Mohamed Sekkat and Sidi Othmane Hospitals in Casablanca, Morocco. Data collection was conducted by two trained interviewers who administered ...
The cluster-based analysis showed that participants in cluster 1 had the highest mean attitude score (13.9 ± 2.15) and percentage of individuals with a high level of knowledge (50.8%) whereas the lowe...
The findings showed that female individuals living in rural settings, belonging to an older age group, who were least likely to use health professionals as an information source had the lowest levels ...
Seizure clustering, is the most frequently reported adverse event in epilepsy monitoring unit (EMU) safety studies which, can also potentiate other adverse events, such as falls, status epilepticus, a...
A retrospective review of patients admitted to the EMU over a two-year period was completed. Data collected included patient demographics, types of epilepsy, seizure frequency, anti-seizure medication...
Two hundred seven patients were included in our study; of these, ninety patients experienced two or more seizures in a 24-hour period (24SC), and 68 patients experienced two or more seizures in a 4-ho...
Our data showed that long-acting ASMs can be protective against seizure clustering. Furthermore, patients with temporal lobe epilepsy, and those on increased numbers of ASMs, were more likely to exper...
Over the last decade, advances in understanding the pathophysiology, clinical presentation, systemic consequences and treatment responses in obstructive sleep apnea (OSA) have made individualised OSA ...
Patients diagnosed with OSA on level 1 polysomnography (PSG) were included. Clinical and co-morbidity profile, anthropometry and sleepiness scores were compiled. On PSG, apnea-hypopnea index, position...
One hundred patients (66 males) with a mean age of 49.5 ± 13.3 years were included. Snoring was reported by 94% subjects, and 50% were excessively sleepy. Two-thirds of subjects had co-morbidities, th...
This study revealed three OSA clusters with distinct demographic, anthropometric and PSG features. Further research with bigger sample size and additional parameters may pave the way for characterisin...
Previous studies suggested that distinct phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA; formerly known as Churg-Strauss syndrome) could be determined by the presence or absence of ...
This study used standardized data of 15 European centers for patients with EGPA fulfilling widely accepted classification criteria. We used multiple correspondence analysis, hierarchical cluster analy...
The analyses included 489 patients diagnosed between 1984 and 2015. ANCA were detected in 37.2% of patients, mostly perinuclear ANCA (85.4%) and/or antimyeloperoxidase (87%). Compared with ANCA-negati...
Although reinforcing the known association of ANCA status with clinical manifestations, cluster analysis does not support a complete separation of EGPA in ANCA-positive and -negative subsets. Collecti...
In the present study, we applied cluster analysis (CA) in SLE patients with joint involvement to identify which disease subset most commonly develops erosive damage....
We collected clinical and laboratory data of SLE patients with a clinical history of joint involvement (arthritis/arthralgia). Ultrasonographic assessment was performed at level of MCPs and PIPs joint...
CA included 112 SLE patients (M/F 6/106; median age 45 years, IQR 17; median disease duration 96 months, IQR 165). Arthritis was observed in 82 patients (73.2%) and inflammatory arthralgia in 30 (26.8...
The application of CA made it possible to better characterise SLE phenotype including erosive arthritis. In particular, feature-driven CA leads to the identification of a more aggressive disease, due ...